Industry News

Mylan NV by striking down two patents held by Israel-based Teva Pharmaceutical Industries Ltd for its blockbuster drug Copaxone 40 mg/mL formulation. "The US PTO has ruled in favor of Mylan in its inter partes review proceeding and found all claims of two related Copaxone 40 mg patents to be unpatentable," Natco said in a statement."/>
US patent office rules in favour of Natco Pharma's US partner Mylan [Mint, New Delhi]
Chembio Diagnostics, Inc., a leader in point-of-care diagnostic tests for infectious diseases, today announced that it has been awarded a contract for up to $13.2 million in total funding from the U.S. Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority for the development and commercialization of the Company’ s rapid POC Zika test and..."/>
Chembio Awarded Up to $13.2 Million U.S. Government Contract to Develop and Commercialize Point-of-Care Tests for Zika Virus
Nix® Launches First-Ever Lice Tracker
Merit Medical Systems, Inc., a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy, today announced that it will present at five investor conferences in September. On Wednesday, September..."/>
Merit Medical to Present at Five Conferences
Provectus Biopharmaceuticals, Inc., a clinical-stage oncology and dermatology biopharmaceutical company, today announced the pricing of a "best efforts" public offering of 240,000 shares of Series B Convertible Preferred Stock and warrants initially exercisable to purchase an aggregate of 24,000,000 shares of common stock with a public offering price of $25.00 for a combination of one share of Series B Convertible Preferred Stock and a warrant to..."/>
Provectus Biopharmaceuticals, Inc. Announces Pricing of Public Offering to Raise $6 Million
OneSavings Bank said it will continue to focus on what it does best. In an interim update the challenger bank said underlying pre-tax profit was pounds sterling 64.6 m in the first six months of the year, up 36 pc on the same period a year ago. Assets on its books have grown 20.8 pc to pounds sterling 6.3 bn."/>
Daily Mail, London, market report column [Daily Mail, London]
MannKind Corporation announced that the United States District Court for the Central District of California has dismissed the class action that was pending against MannKind Corporation and two of its executives. The Court granted the defendants’ motion to dismiss the plaintiffs’ amended class action complaint without leave to amend, thereby closing the case. The plaintiffs can appeal the decision within 30 days.."/>
Securities Class Action Against MannKind Dismissed
Capstone Therapeutics Corp. and LipimetiX Development, Inc., the Company’ s drug development joint venture announced today that the JV’ s Series B-1 preferred stock offering totaling $1,012,000 closed on August 25, 2016. Individual accredited investors and management participated in the financing. Evolution Venture Partners, a NY-based investment bank, has been engaged to advise the JV on corporate finance matters."/>
Capstone Therapeutics Announces That Its Joint Venture, LipimetiX Development, Inc., Has Closed a Series B-1 Preferred Stock Offering
Halyard Health, Inc. and Kimberly-Clark Corporation on behalf of investors who purchased or otherwise acquired Kimberly-Clark securities on or after February 25, 2013 and received Halyard securities in connection with Kimberly-Clark’ s spin-off of Halyard in October..."/>
Kessler Topaz Meltzer & Check, LLP Announces Final Deadline Reminder for Halyard Health, Inc. and Kimberly-Clark Corporation Shareholders
Propanc Health Group Corporation, an emerging healthcare company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian and colorectal cancers, today announced that it has retained KCSA Strategic Communications, a leading New York-based communications firm, to lead the Company's investor relations and public relations programs. KCSA will deploy a..."/>
Propanc Retains KCSA Strategic Communications as Investor Relations and Public Relations Counsel
OptimizeRx Corp., a health technology software company whose premier content-delivery platform enables pharmaceutical companies to provide on-demand patient-care has been invited to present at the 2016 Gateway Conference being held on September 7-8, 2016 at the Four Seasons Hotel San Francisco.. OptimizeRx CEO William Febbo is scheduled to present on Wednesday, September 7 at 8:30 a.m. Pacific time, with one-on-one meetings held throughout..."/>
OptimizeRx to Present at the 5th Annual Liolios Gateway Conference on September 7, 2016
Baxter’ s industry-leading AMIA APD system with SHARESOURCE, REVACLEAR high-flux dialyzer and CRRT products. DEERFIELD, Ill.---- Baxter International Inc., a global leader in renal care, and Satellite Healthcare, a leading, national not-for-profit and the sixth largest provider of patient-centered dialysis and kidney..."/>
Baxter and Satellite Healthcare Partner to Bring Innovative Dialysis Care to More Patients
Bioanalytical Systems, Inc., a recognized global leader in the development of instrumentation for automated blood sampling in animal models, is proud to announce its launch of the Embrace Automation grant program featuring the BASi Culex NxT™ Automated Blood Sampling system and Raturn™. As laboratory techniques and instrumentation evolved, many formerly manual processes became automated— from basic pipetting to intricate high-throughput..."/>
BASi Launches Embrace Automation Grant Program with Culex NxT™ Automated Blood Sampling System
ChemoCentryx, Inc.,, a clinical-stage biopharmaceutical company developing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders, and cancer, today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the Baird 2016 Global Healthcare Conference on Wednesday, September 7, 2016 at 3:45 p.m. ET. The conference will be held at the New York Palace Hotel in New York, NY.."/>
ChemoCentryx to Present at the Baird 2016 Global Healthcare Conference
WellCare Health Plans, Inc., announced today that it named William "Bill" Jones state president, effective Aug. 25, 2016. Jones will be responsible for WellCare's Medicaid and Medicare Advantage businesses across the Commonwealth. He will report to Kelly Munson, WellCare's senior vice president, division president and Medicaid product."/>
WellCare Names William Jones State President, Kentucky
Simulations Plus, Inc., the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that it has released version 1.0 of PKPlus, its next-generation software for analysis of preclinical and clinical trial data. Mark Pflieger, product manager for PKPlus, said:“ More than two years in the making, we..."/>
Simulations Plus Releases PKPlus™ Version 1.0
Leatt Corporation, a global developer, marketer and distributor of personal protective equipment for all forms of sports, and whose products include the flagship Leatt-Brace ®, announced today the introduction of its new 2017 Bicycling Range, expanding its existing product portfolio of protection gear, backpacks and gloves to include all-new helmets and, for the first time, a line of cycling apparel designed for a wider group of..."/>
Leatt Introduces 2017 Bicycling Range Featuring New Helmet Technology, Cycling Apparel
Akorn, Inc., a leading specialty pharmaceutical company, today announced that it has relaunched Ofloxacin Otic Solution 0.3%, a sterile aqueous anti-infective solution for otic use. About Ofloxacin Otic Solution Ofloxacin Otic Solution is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below:. Otitis Externa in adults and pediatric patients, 6 months..."/>
Akorn Relaunches Ofloxacin Otic Solution
TapImmune Inc., a clinical-stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer& metastatic disease, is pleased to announce the appointment of Michael J. Loiacono as its Chief Financial Officer and Chief Accounting Officer. Michael will also act as Corporate Secretary."/>
TapImmune Appoints Michael J. Loiacono as Chief Financial Officer
Aytu BioScience Inc., a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced today that the company will present its operational results for the fourth and final quarter of fiscal 2016 on Thursday, September 1, 2016, at 4:30 p.m. ET. The company will review recent accomplishments and provide an overview of its business and growth strategy, as well as its financial..."/>
Aytu BioScience to Provide Fiscal Fourth Quarter and Fiscal 2016 Business Update
Cigna has become the first national insurer to cover three-dimensional mammograms for routine breast cancer screening. Medicare and Connecticut's Medicaid program already cover the technology for routine mammograms, which are free to women 40 and older with insurance since Obamacare's passage. But Cigna, Aetna, UnitedHealthcare and Anthem were hesitant, as there is not yet clear data to show that 3- D mammograms save more lives than traditional mammograms."/>
Cigna Becomes First National Insurer To Cover 3-D Mammograms [The Hartford Courant]
Misonix, Inc., an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, hosted a successful BoneScalpel Hands-On Workshop during the Scoliosis Research Society Worldwide Conference, 2016 held in Bali, Indonesia last week. Twenty surgeons attended the workshop and received training..."/>
BoneScalpel® Hands-On Workshop Draws 20 Surgeons at the 2016 Scoliosis Research Society Worldwide Conference in Bali, Indonesia

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Consumer Discretionary722 Articles
Information Technology679 Articles
Financials567 Articles
Health Care401 Articles
Industrials393 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at